The anti-cancer drug pembrolizumab has shown promise in slowing or stopping the progression of progressive multifocal leukoencephalopathy (PML), a typically fatal infection of the brain caused by the JC virus (JCV).
Press Releases
Displaying 131 - 140 of 253
Wednesday, April 10, 2019
Monday, March 18, 2019
NIH study finds new cell composition may lead to less effective future response
Friday, March 15, 2019
NIH study suggests tiny electrical brain waves may be a hallmark of successful memory retrieval
Wednesday, February 6, 2019
Image
Wednesday, January 2, 2019
Image
Friday, November 2, 2018
NIH announces new round of awards for cutting-edge brain research
Wednesday, October 31, 2018
National Institutes of Health directors will discuss how NIH is marshalling resources, primarily through the HEAL (Helping to End Addiction Long-term) Initiative, to come up with short- and long-term solutions for countering the pain and opioid crisis.